id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-0030-0316,FDA,FDA-2015-N-0030,Testimony from International Academy of Compounding Pharmacists (IACP),Other,Testimony,2017-06-09T04:00:00Z,2017,6,2017-06-09T04:00:00Z,,2017-06-09T15:38:19Z,,0,0,09000064826aef0f